Massive Bio to Provide AI Analytics to Precision Cancer Consortium
The bioinformatics firm hopes to help the coalition of biopharmaceutical companies improve oncology clinical trial matching and access to NGS testing.
Stay updated with breaking news from Massive Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The bioinformatics firm hopes to help the coalition of biopharmaceutical companies improve oncology clinical trial matching and access to NGS testing.
New York City-based Massive Bio, which uses artificial intelligence to match cancer patients to clinical trials, continues to grow outside the United States Massive Bio, which uses artificial intelligence
Research has even shown that cancer diagnosis can be significantly improved using AI, with real-time data updates, personalized attention, and ultimately better results at lower costs.
Massive Bio announced the launch of "Donation for Life," a new awareness campaign created to support cancer associations and foundations in the United...
Massive Bio has been named a quarterfinalist in the annual UCSF | Health Hub: Digital Health Awards, which recognize health tech companies that are driving innovation and improving delivery of healthcare.NEW YORK--(BUSINESS WIRE)--#AI--Massive Bio has been named a Best in Class Quarterfinalist in the UCSF | Health H...